Disease Education Resources
Dermatology
Explore our library of Lilly-created medical education resources.
Atopic Dermatitis
A Look at The Future: Biologic Therapies in Atopic Dermatitis
Dr. Lisa Beck looks at biologics for atopic dermatitis to explain the differences between targeting the IL-13 cytokine and IL-4Rα.
Beyond the Surface: Assessing Atopic Dermatitis in Patients with Skin of Color
Dr. Andrew Alexis discusses different ways to assess atopic dermatitis in patients with skin of color.
Disease Severity and Care Delays in Patients with Skin of Color and Atopic Dermatitis
Dr. Andrew Alexis discusses disease severity and delays in care for patients with skin of color and atopic dermatitis.
Expert Insights in Atopic Dermatitis (AD)
A series of short videos featuring International Thought Leaders to raise awareness and increase understanding of the key challenges in management of AD that combines evidence-based research with expert insights to provide meaningful, patient-centric education.
How to Decide When to Move to a Systemic and Target IL-13 Versus IL-4 in AD
Dr Sarina Elmariah discusses when to recommend systemic therapy in patients with AD and if the therapy should target IL-13 or IL-4.
IL-13 in Atopic Dermatitis
This video describes the role of the cytokine IL-13 in the pathophysiology of atopic dermatitis, as well as IL-13 signaling.
Systemic Patient in Atopic Dermatitis: Itch-dominant Patients
Dr. Jonathan Silverberg and Dr. Eric Simpson discuss the concept of “itch-dominant patients” as a true subset of atopic dermatitis and highlight a real-world study with longitudinal data.
Systemic Patient in Atopic Dermatitis: Key Questions for Identification
Dr. Jonathan Silverberg and Dr. Eric Simpson discuss key questions to ask a patient with atopic dermatitis when assessing if the patient is eligible for an advanced systemic therapy.
Systemic Patient in Atopic Dermatitis: Long-term Control
Dr. Jonathan Silverberg and Dr. Eric Simpson share clinical study data to elaborate on the importance of long-term disease control and symptom fluctuation for patients with atopic dermatitis.
Systemic Patient in Atopic Dermatitis: Who is a Systemic Patient?
Dr. Jonathan Silverberg and Dr. Eric Simpson discuss how to define a systemic patient with atopic dermatitis based on topical treatment failure.
Targeting IL-13: Does It Scratch the Itch in Atopic Dermatitis?
Dr. Sarina Elmariah discusses the roles of IL-13 and itch in atopic dermatitis.
The AD Saga: Measuring Eligibility for Systemic Therapy
A video exploring the GUIDE TO ADVANCE SYSTEMATIC THERAPY IN AD with expert insights from Dr. Gooderham and Dr. Silverberg.
The Central Role of IL-13 in AD
A short video presented by Prof. Gil Yosipovitch on the Central Role of IL-13 in AD.
The Saga Concludes Assessing Lack of Treatment Response in Patients with AD
A video exploring section C of the GUIDE TO ADVANCE SYSTEMATIC THERAPY IN AD with expert insights from Dr Gooderham and Dr Silverberg.
The Saga Continues Assessing Clinical Severity in Patients with AD
A video exploring section A of the GUIDE TO ADVANCE SYSTEMATIC THERAPY IN AD with expert insights from Dr Gooderham and Dr Silverberg.
The Saga Continues Assessing Subjective Burden in Patients with AD
A video exploring section B of the GUIDE TO ADVANCE SYSTEMATIC THERAPY IN AD with expert insights from Dr Gooderham and Dr Silverberg.
Understanding Clinical Assessments of Atopic Dermatitis in Patients with Skin of Color
Dr. Andrew Alexis discusses clinical trials and scales used in assessing atopic dermatitis in patients with skin of color.
Resource for dermatologists that can be used to facilitate a thoughtful 30-minute debate with a peer around when an atopic dermatitis patient is eligible for an advanced systemic treatment.
A resource for health care professionals to effectively assess and treat atopic dermatitis (AD) in patients with skin of color.
A resource for health care professionals to recognize and manage mental health comorbidities in their patients with atopic dermatitis.
A guide to support clinician decision-making on when to start systemic therapy. Systemic therapy is indicated when at least 1 criterion in each section is fulfilled.
An infographic describing the role of IL-13 in atopic dermatitis.
An infographic describing the MoA of three approved biologics that target IL-13 signaling.
Patient Education Resources
Explore our library of patient based education materials to aid in HCP to patient interactions.